相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
Margaux Lejeune et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19
Peter Hegyi et al.
GASTROENTEROLOGY (2020)
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors A Phase 1 Dose-Escalation Trial
Melissa L. Johnson et al.
JAMA ONCOLOGY (2019)
Camrelizumab: First Global Approval
Anthony Markham et al.
DRUGS (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
Cancer stem cells as targets for immunotherapy
Amy S. Codd et al.
IMMUNOLOGY (2018)
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles
Barbara Colzani et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Bispecific antibodies for cancer therapy: A review
Anuradha Krishnamurthy et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells
Marta Truffi et al.
SCIENTIFIC REPORTS (2018)
The benefit and risk of nivolumab in non-small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials
Binghao Zhao et al.
CANCER MEDICINE (2018)
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma A Preplanned Interim Analysis of a Clinical Trial
Sandra P. D'Angelo et al.
JAMA ONCOLOGY (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Monoclonal antibodies in cancer immunotherapy
Ilgin Kimiz-Gebologlu et al.
MOLECULAR BIOLOGY REPORTS (2018)
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati et al.
FRONTIERS IN IMMUNOLOGY (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report
Lucio Lara Santos et al.
CASE REPORTS IN ONCOLOGY (2018)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Y. Dirix et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
Jayamanti Pandit et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Introduction to checkpoint inhibitors and cancer immunotherapy INTRODUCTION
Arlene H. Sharpe
IMMUNOLOGICAL REVIEWS (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
Epstein-Barr virus-associated lymphomas
Claire Shannon-Lowe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Type I Interferons and Natural Killer Cell Regulation in Cancer
Lena Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma
Wendy K. Nevala et al.
SCIENTIFIC REPORTS (2017)
Therapeutic antibodies against cancer stem cells: a promising approach
Smarakan Sneha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
Jessica C. Hassel et al.
CANCER TREATMENT REVIEWS (2017)
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Rimda Wanchoo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
Zishuo I. Hu et al.
CURRENT BREAST CANCER REPORTS (2017)
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunity
Patrizia Mondello et al.
ONCOTARGET (2016)
Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy
Ashish Kulkarni et al.
ACS NANO (2016)
Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors
Yanqi Ye et al.
ACS NANO (2016)
Trastuzumab in the Treatment of Breast Cancer
Sofia Maximiano et al.
BIODRUGS (2016)
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
Thomas K. Eigentler et al.
CANCER TREATMENT REVIEWS (2016)
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
IFN-λ cancer immunotherapy: new kid on the block
Ahmed Lasfar et al.
IMMUNOTHERAPY (2016)
Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Shi-Yong Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
Xiaopin Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy
Kuangda Lu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
Scott Antonia et al.
LANCET ONCOLOGY (2016)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Chao Wang et al.
NANO LETTERS (2016)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He et al.
NATURE COMMUNICATIONS (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
Gennaro Riccio et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Accelerating the Translation of Nanomaterials in Biomedicine
Samir Mitragotri et al.
ACS NANO (2015)
Recent Therapeutic Advances in the Treatment of Colorectal Cancer
Kristen K. Ciombor et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Rodney A. Rosalia et al.
BIOMATERIALS (2015)
Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
Michael S. Goldberg
CELL (2015)
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Michele Cioffi et al.
CLINICAL CANCER RESEARCH (2015)
Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy
Jianbao Gao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
Tobias Ruck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells
Ying Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prospects of immune checkpoint modulators in the treatment of glioblastoma
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2015)
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
Madappa Kundranda et al.
Drug Design Development and Therapy (2015)
PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses
Mingshui Chen et al.
CELLULAR IMMUNOLOGY (2014)
Bevacizumab: A Review of Its Use in Advanced Cancer
Gillian M. Keating
DRUGS (2014)
Complement in monoclonal antibody therapy of cancer
Laura M. Rogers et al.
IMMUNOLOGIC RESEARCH (2014)
Insight into nanoparticle cellular uptake and intracellular targeting
Basit Yameen et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem- like cell activity in multiple myeloma
Cuiping Yang et al.
NANOMEDICINE (2014)
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
Laura M. Alwan et al.
TARGETED ONCOLOGY (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
Yichun Qian et al.
SCIENTIFIC REPORTS (2014)
Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells
Ming-Ying Lan et al.
AURIS NASUS LARYNX (2013)
Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model
Hao-Wen Kao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer
Niranjan Awasthi et al.
CARCINOGENESIS (2013)
Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine
Kae Pusic et al.
FASEB JOURNAL (2013)
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
Michael E. Werner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation.
Shradha S. Khurana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy
Luca Bologna et al.
JOURNAL OF IMMUNOLOGY (2013)
Nanometric gold in cancer nanotechnology: current status and future prospect
Mohammad Zaki Ahmad et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Vaccine delivery using nanoparticles
Anthony E. Gregory et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Particle-mediated delivery of cytokines for immunotherapy
David A. Christian et al.
IMMUNOTHERAPY (2012)
Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment
Ligeng Xu et al.
NANO LETTERS (2012)
Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole
Ji-Sun Lim et al.
NANOTECHNOLOGY (2012)
Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
Berna Bozkurt Duman et al.
MEDICAL ONCOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
Viktor Gruenwald et al.
ACTA ONCOLOGICA (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
Xiaowen Ge et al.
CLINICAL CANCER RESEARCH (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Cytokines and the inception of CD8 T cell responses
Maureen A. Cox et al.
TRENDS IN IMMUNOLOGY (2011)
Prevention of type 1 diabetes mellitus using a novel vaccine
Tihamer Orban et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2011)
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
S. J. O'Day et al.
ANNALS OF ONCOLOGY (2010)
Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy
Claude Sportes et al.
CLINICAL CANCER RESEARCH (2010)
Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
Bruce D. Cheson
JOURNAL OF CLINICAL ONCOLOGY (2010)
Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
Hakan C. Steen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
Simone Mocellin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Matthias T. Stephan et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
J. Griggs et al.
BRITISH JOURNAL OF CANCER (2009)
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy
E. Martinelli et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
TamerA. El Bayoumil et al.
CLINICAL CANCER RESEARCH (2009)
Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
Dennis Christensen et al.
JOURNAL OF LIPOSOME RESEARCH (2009)
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Shlomo Z. Ben-Sasson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function
Redas Trepiakas et al.
VACCINE (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Serum lipids regulate dendritic cell CD1 expression and function
David S. Leslie et al.
IMMUNOLOGY (2008)
Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery
Raquel Mejias et al.
JOURNAL OF CONTROLLED RELEASE (2008)
A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells
Erin R. Steenblock et al.
MOLECULAR THERAPY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells
Tao Yang et al.
PHARMACEUTICAL RESEARCH (2007)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice
Bhawna Gupta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
The interferons: 50 years after their discovery, there is much more to learn
Sidney Pestka
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice
Mircea C. Popescu et al.
BLOOD (2007)
Cetuximab - A review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer
Stephanie K. A. Blick et al.
DRUGS (2007)
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus
Patricia L. Mottram et al.
MOLECULAR PHARMACEUTICS (2007)
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery
Nobuhiro Nishiyama et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer
Lee M. Ellis
SEMINARS IN ONCOLOGY (2006)
CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells
Tomoko Watanabe et al.
CLINICAL IMMUNOLOGY (2006)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model
Hong He et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Development and characterization of interleukin-18-loaded biodegradable microspheres
F. Lagarce et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells
SA Rosenberg et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Hepatocellular carcinoma and hepatitis B virus
HLY Chan et al.
SEMINARS IN LIVER DISEASE (2006)
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I
H Hasegawa et al.
NATURE MEDICINE (2006)
The structure of the interleukin-15α receptor and its implications for ligand binding
I Lorenzen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma
Brendan D. Curti
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-Specific cell responses
S Bryde et al.
BIOCONJUGATE CHEMISTRY (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals
YM Huh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer
SF Wong
CLINICAL THERAPEUTICS (2005)
The history of vaccines and immunization: Familiar patterns, new challenges
AM Stern et al.
HEALTH AFFAIRS (2005)
Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates
TM Allen et al.
CLINICAL CANCER RESEARCH (2005)
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging
YW Jun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles
SH Sun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors
TC Wagner et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
SS Neelapu et al.
CLINICAL CANCER RESEARCH (2004)
Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses
PV Sivakumar et al.
IMMUNOLOGY (2004)
Mircoparticlulate formulations for the controlled release of interleukin-2
TT Thomas et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers
M Mancini-Bourgine et al.
HEPATOLOGY (2004)
Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery
GF Paciotti et al.
DRUG DELIVERY (2004)
Interleukin-21 inhibits dendritic cell activation and maturation
K Brandt et al.
BLOOD (2003)
Interleukin-21 inhibits dendritic cell-mediated t cell activation and induction of contact hypersensitivity in vivo
K Brandt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
IL-21: A novel IL-2-family lymphokine that modulates B,T, and natural killer cell responses
T Habib et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma
T Kishida et al.
MOLECULAR THERAPY (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
GM-CSF-secreting melanoma vaccines
G Dranoff
ONCOGENE (2003)
The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells
TK Means et al.
JOURNAL OF IMMUNOLOGY (2003)
In vivo survival and homeostatic proliferation of natural killer cells
M Prlic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: A novel treatment for experimental malignant glioma
LD Rhines et al.
NEUROSURGERY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)
M Akasheh et al.
BONE MARROW TRANSPLANTATION (2003)
Viruses and interferon: A fight for supremacy
MG Katze et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Size-controlled synthesis of magnetite nanoparticles
SH Sun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Suppression of lymphoma and epithelial malignancies effected by interferon γ
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Interferon-β from melanoma cells suppresses the proliferations of melanoma cells in an autocrine manner
H Satomi et al.
CYTOKINE (2002)
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
AA Lighvani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dendritic cell delivery of plasmid DNA - Applications for controlled genetic immunization
RJ Mumper et al.
MOLECULAR BIOTECHNOLOGY (2001)
Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors
J Hanes et al.
PHARMACEUTICAL RESEARCH (2001)
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages
N Schöler et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Interferon-γ inducible exchanges of 20S proteasome active site subunits:: Why?
M Groettrup et al.
BIOCHIMIE (2001)
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
E Jonasch et al.
ONCOLOGIST (2001)
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
J Parrish-Novak et al.
NATURE (2000)
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
KS Schluns et al.
NATURE IMMUNOLOGY (2000)
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
J Marks-Konczalik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Controlled-release, pegylation, liposomal formulations: New mechanisms in the delivery of injectable drugs
KR Reddy
ANNALS OF PHARMACOTHERAPY (2000)
Regulatory T cells: Key controllers of immunologic self-tolerance
S Sakaguchi
CELL (2000)
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes
SV Kotenko et al.
ONCOGENE (2000)
Cytokine receptor signaling pathways
WJ Leonard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Control of homeostasis of CD8+ memory T cells by opposing cytokines
CC Ku et al.
SCIENCE (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
